Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia
The 2-oxoglutarate dehydrogenase-like (OGDHL) protein is a rate-limiting enzyme in the Krebs cycle that plays a pivotal role in mitochondrial metabolism. OGDHL expression is restricted mainly to the brain in humans. Here, we report nine individuals from eight unrelated families carrying bi-allelic v...
Gespeichert in:
Veröffentlicht in: | American journal of human genetics 2021-12, Vol.108 (12), p.2368-2384 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2384 |
---|---|
container_issue | 12 |
container_start_page | 2368 |
container_title | American journal of human genetics |
container_volume | 108 |
creator | Yap, Zheng Yie Efthymiou, Stephanie Seiffert, Simone Vargas Parra, Karen Lee, Sukyeong Nasca, Alessia Maroofian, Reza Schrauwen, Isabelle Pendziwiat, Manuela Jung, Sunhee Bhoj, Elizabeth Striano, Pasquale Mankad, Kshitij Vona, Barbara Cuddapah, Sanmati Wagner, Anja Alvi, Javeria Raza Davoudi-Dehaghani, Elham Fallah, Mohammad-Sadegh Gannavarapu, Srinitya Lamperti, Costanza Legati, Andrea Murtaza, Bibi Nazia Nadeem, Muhammad Shahid Rehman, Mujaddad Ur Saeidi, Kolsoum Salpietro, Vincenzo von Spiczak, Sarah Sandoval, Abigail Zeinali, Sirous Zeviani, Massimo Reich, Adi Jang, Cholsoon Helbig, Ingo Barakat, Tahsin Stefan Ghezzi, Daniele Leal, Suzanne M. Weber, Yvonne Houlden, Henry Yoon, Wan Hee |
description | The 2-oxoglutarate dehydrogenase-like (OGDHL) protein is a rate-limiting enzyme in the Krebs cycle that plays a pivotal role in mitochondrial metabolism. OGDHL expression is restricted mainly to the brain in humans. Here, we report nine individuals from eight unrelated families carrying bi-allelic variants in OGDHL with a range of neurological and neurodevelopmental phenotypes including epilepsy, hearing loss, visual impairment, gait ataxia, microcephaly, and hypoplastic corpus callosum. The variants include three homozygous missense variants (p.Pro852Ala, p.Arg244Trp, and p.Arg299Gly), three compound heterozygous single-nucleotide variants (p.Arg673Gln/p.Val488Val, p.Phe734Ser/p.Ala327Val, and p.Trp220Cys/p.Asp491Val), one homozygous frameshift variant (p.Cys553Leufs∗16), and one homozygous stop-gain variant (p.Arg440Ter). To support the pathogenicity of the variants, we developed a novel CRISPR-Cas9-mediated tissue-specific knockout with cDNA rescue system for dOgdh, the Drosophila ortholog of human OGDHL. Pan-neuronal knockout of dOgdh led to developmental lethality as well as defects in Krebs cycle metabolism, which was fully rescued by expression of wild-type dOgdh. Studies using the Drosophila system indicate that p.Arg673Gln, p.Phe734Ser, and p.Arg299Gly are severe loss-of-function alleles, leading to developmental lethality, whereas p.Pro852Ala, p.Ala327Val, p.Trp220Cys, p.Asp491Val, and p.Arg244Trp are hypomorphic alleles, causing behavioral defects. Transcript analysis from fibroblasts obtained from the individual carrying the synonymous variant (c.1464T>C [p.Val488Val]) in family 2 showed that the synonymous variant affects splicing of exon 11 in OGDHL. Human neuronal cells with OGDHL knockout exhibited defects in mitochondrial respiration, indicating the essential role of OGDHL in mitochondrial metabolism in humans. Together, our data establish that the bi-allelic variants in OGDHL are pathogenic, leading to a Mendelian neurodevelopmental disease in humans. |
doi_str_mv | 10.1016/j.ajhg.2021.11.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8715183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002929721004158</els_id><sourcerecordid>2600284077</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-a30eb015d208fa23e24b9a7abe98604271b11e6fe4fec3b8394364c10d2383913</originalsourceid><addsrcrecordid>eNp9kc2O1DAQhC0EYoeFF-CAfOQwCW47vxJCggV2kUbaC5ytjtOZ8cj5wU4i9g14bDzMsoILJ8v2V9WtKsZegkhBQPHmmOLxsE-lkJACpEKoR2wDuSqTohD5Y7YRQsiklnV5wZ6FcBQCoBLqKbtQWRXpQm3Yzw82QefIWcNX9BaHOXA78Nvrjzc7bnAJxJEPtPixpZXcOPU0zOh4mMjMful5awNhpDrCefF22HOarKMp3G35gfD3ixtD2PLVhiUqbT-h9SebLceh5TjjD4vP2ZMOXaAX9-cl-_b509erm2R3e_3l6v0uMVmezwkqQY2AvJWi6lAqkllTY4kN1VUhMllCA0BFR1lHRjWVqjNVZAZEK1W8gLpk786-09L01Jq4hkenJ2979Hd6RKv__RnsQe_HVVcl5FCpaPD63sCP3xcKs-5tMOQcDjQuQcsipl5loiwjKs-o8TEAT93DGBD6VKE-6lOF-lShBtCxlCh69feCD5I_nUXg7RmgGNNqyetgLA2GWutjJ7od7f_8fwHIBK_g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2600284077</pqid></control><display><type>article</type><title>Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ScienceDirect Journals (5 years ago - present)</source><source>PubMed Central</source><creator>Yap, Zheng Yie ; Efthymiou, Stephanie ; Seiffert, Simone ; Vargas Parra, Karen ; Lee, Sukyeong ; Nasca, Alessia ; Maroofian, Reza ; Schrauwen, Isabelle ; Pendziwiat, Manuela ; Jung, Sunhee ; Bhoj, Elizabeth ; Striano, Pasquale ; Mankad, Kshitij ; Vona, Barbara ; Cuddapah, Sanmati ; Wagner, Anja ; Alvi, Javeria Raza ; Davoudi-Dehaghani, Elham ; Fallah, Mohammad-Sadegh ; Gannavarapu, Srinitya ; Lamperti, Costanza ; Legati, Andrea ; Murtaza, Bibi Nazia ; Nadeem, Muhammad Shahid ; Rehman, Mujaddad Ur ; Saeidi, Kolsoum ; Salpietro, Vincenzo ; von Spiczak, Sarah ; Sandoval, Abigail ; Zeinali, Sirous ; Zeviani, Massimo ; Reich, Adi ; Jang, Cholsoon ; Helbig, Ingo ; Barakat, Tahsin Stefan ; Ghezzi, Daniele ; Leal, Suzanne M. ; Weber, Yvonne ; Houlden, Henry ; Yoon, Wan Hee</creator><creatorcontrib>Yap, Zheng Yie ; Efthymiou, Stephanie ; Seiffert, Simone ; Vargas Parra, Karen ; Lee, Sukyeong ; Nasca, Alessia ; Maroofian, Reza ; Schrauwen, Isabelle ; Pendziwiat, Manuela ; Jung, Sunhee ; Bhoj, Elizabeth ; Striano, Pasquale ; Mankad, Kshitij ; Vona, Barbara ; Cuddapah, Sanmati ; Wagner, Anja ; Alvi, Javeria Raza ; Davoudi-Dehaghani, Elham ; Fallah, Mohammad-Sadegh ; Gannavarapu, Srinitya ; Lamperti, Costanza ; Legati, Andrea ; Murtaza, Bibi Nazia ; Nadeem, Muhammad Shahid ; Rehman, Mujaddad Ur ; Saeidi, Kolsoum ; Salpietro, Vincenzo ; von Spiczak, Sarah ; Sandoval, Abigail ; Zeinali, Sirous ; Zeviani, Massimo ; Reich, Adi ; Jang, Cholsoon ; Helbig, Ingo ; Barakat, Tahsin Stefan ; Ghezzi, Daniele ; Leal, Suzanne M. ; Weber, Yvonne ; Houlden, Henry ; Yoon, Wan Hee ; SYNaPS Study Group ; University of Washington Center for Mendelian Genomics</creatorcontrib><description>The 2-oxoglutarate dehydrogenase-like (OGDHL) protein is a rate-limiting enzyme in the Krebs cycle that plays a pivotal role in mitochondrial metabolism. OGDHL expression is restricted mainly to the brain in humans. Here, we report nine individuals from eight unrelated families carrying bi-allelic variants in OGDHL with a range of neurological and neurodevelopmental phenotypes including epilepsy, hearing loss, visual impairment, gait ataxia, microcephaly, and hypoplastic corpus callosum. The variants include three homozygous missense variants (p.Pro852Ala, p.Arg244Trp, and p.Arg299Gly), three compound heterozygous single-nucleotide variants (p.Arg673Gln/p.Val488Val, p.Phe734Ser/p.Ala327Val, and p.Trp220Cys/p.Asp491Val), one homozygous frameshift variant (p.Cys553Leufs∗16), and one homozygous stop-gain variant (p.Arg440Ter). To support the pathogenicity of the variants, we developed a novel CRISPR-Cas9-mediated tissue-specific knockout with cDNA rescue system for dOgdh, the Drosophila ortholog of human OGDHL. Pan-neuronal knockout of dOgdh led to developmental lethality as well as defects in Krebs cycle metabolism, which was fully rescued by expression of wild-type dOgdh. Studies using the Drosophila system indicate that p.Arg673Gln, p.Phe734Ser, and p.Arg299Gly are severe loss-of-function alleles, leading to developmental lethality, whereas p.Pro852Ala, p.Ala327Val, p.Trp220Cys, p.Asp491Val, and p.Arg244Trp are hypomorphic alleles, causing behavioral defects. Transcript analysis from fibroblasts obtained from the individual carrying the synonymous variant (c.1464T>C [p.Val488Val]) in family 2 showed that the synonymous variant affects splicing of exon 11 in OGDHL. Human neuronal cells with OGDHL knockout exhibited defects in mitochondrial respiration, indicating the essential role of OGDHL in mitochondrial metabolism in humans. Together, our data establish that the bi-allelic variants in OGDHL are pathogenic, leading to a Mendelian neurodevelopmental disease in humans.</description><identifier>ISSN: 0002-9297</identifier><identifier>EISSN: 1537-6605</identifier><identifier>DOI: 10.1016/j.ajhg.2021.11.003</identifier><identifier>PMID: 34800363</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alleles ; Animals ; Ataxia - genetics ; bi-allelic ; Cells, Cultured ; Child ; Cohort Studies ; CRISPR-Cas9 gene editing ; DEE ; developmental and epileptic encephalopathy ; DNA Mutational Analysis ; Drosophila ; Drosophila melanogaster - genetics ; Epilepsy - genetics ; exome sequencing ; Family Health ; Female ; Fibroblasts ; Hearing Loss - genetics ; Humans ; Ketoglutarate Dehydrogenase Complex - genetics ; Male ; mitochondria ; Mutation ; neurodevelopmental disease ; Neurodevelopmental Disorders - genetics ; OGDHL ; RNA Splicing ; Vision Disorders - genetics ; α-ketoglutarate</subject><ispartof>American journal of human genetics, 2021-12, Vol.108 (12), p.2368-2384</ispartof><rights>2021 American Society of Human Genetics</rights><rights>Copyright © 2021 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.</rights><rights>2021 American Society of Human Genetics. 2021 American Society of Human Genetics</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-a30eb015d208fa23e24b9a7abe98604271b11e6fe4fec3b8394364c10d2383913</citedby><cites>FETCH-LOGICAL-c455t-a30eb015d208fa23e24b9a7abe98604271b11e6fe4fec3b8394364c10d2383913</cites><orcidid>0000-0002-9459-3139</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715183/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajhg.2021.11.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3550,27924,27925,45995,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34800363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yap, Zheng Yie</creatorcontrib><creatorcontrib>Efthymiou, Stephanie</creatorcontrib><creatorcontrib>Seiffert, Simone</creatorcontrib><creatorcontrib>Vargas Parra, Karen</creatorcontrib><creatorcontrib>Lee, Sukyeong</creatorcontrib><creatorcontrib>Nasca, Alessia</creatorcontrib><creatorcontrib>Maroofian, Reza</creatorcontrib><creatorcontrib>Schrauwen, Isabelle</creatorcontrib><creatorcontrib>Pendziwiat, Manuela</creatorcontrib><creatorcontrib>Jung, Sunhee</creatorcontrib><creatorcontrib>Bhoj, Elizabeth</creatorcontrib><creatorcontrib>Striano, Pasquale</creatorcontrib><creatorcontrib>Mankad, Kshitij</creatorcontrib><creatorcontrib>Vona, Barbara</creatorcontrib><creatorcontrib>Cuddapah, Sanmati</creatorcontrib><creatorcontrib>Wagner, Anja</creatorcontrib><creatorcontrib>Alvi, Javeria Raza</creatorcontrib><creatorcontrib>Davoudi-Dehaghani, Elham</creatorcontrib><creatorcontrib>Fallah, Mohammad-Sadegh</creatorcontrib><creatorcontrib>Gannavarapu, Srinitya</creatorcontrib><creatorcontrib>Lamperti, Costanza</creatorcontrib><creatorcontrib>Legati, Andrea</creatorcontrib><creatorcontrib>Murtaza, Bibi Nazia</creatorcontrib><creatorcontrib>Nadeem, Muhammad Shahid</creatorcontrib><creatorcontrib>Rehman, Mujaddad Ur</creatorcontrib><creatorcontrib>Saeidi, Kolsoum</creatorcontrib><creatorcontrib>Salpietro, Vincenzo</creatorcontrib><creatorcontrib>von Spiczak, Sarah</creatorcontrib><creatorcontrib>Sandoval, Abigail</creatorcontrib><creatorcontrib>Zeinali, Sirous</creatorcontrib><creatorcontrib>Zeviani, Massimo</creatorcontrib><creatorcontrib>Reich, Adi</creatorcontrib><creatorcontrib>Jang, Cholsoon</creatorcontrib><creatorcontrib>Helbig, Ingo</creatorcontrib><creatorcontrib>Barakat, Tahsin Stefan</creatorcontrib><creatorcontrib>Ghezzi, Daniele</creatorcontrib><creatorcontrib>Leal, Suzanne M.</creatorcontrib><creatorcontrib>Weber, Yvonne</creatorcontrib><creatorcontrib>Houlden, Henry</creatorcontrib><creatorcontrib>Yoon, Wan Hee</creatorcontrib><creatorcontrib>SYNaPS Study Group</creatorcontrib><creatorcontrib>University of Washington Center for Mendelian Genomics</creatorcontrib><title>Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia</title><title>American journal of human genetics</title><addtitle>Am J Hum Genet</addtitle><description>The 2-oxoglutarate dehydrogenase-like (OGDHL) protein is a rate-limiting enzyme in the Krebs cycle that plays a pivotal role in mitochondrial metabolism. OGDHL expression is restricted mainly to the brain in humans. Here, we report nine individuals from eight unrelated families carrying bi-allelic variants in OGDHL with a range of neurological and neurodevelopmental phenotypes including epilepsy, hearing loss, visual impairment, gait ataxia, microcephaly, and hypoplastic corpus callosum. The variants include three homozygous missense variants (p.Pro852Ala, p.Arg244Trp, and p.Arg299Gly), three compound heterozygous single-nucleotide variants (p.Arg673Gln/p.Val488Val, p.Phe734Ser/p.Ala327Val, and p.Trp220Cys/p.Asp491Val), one homozygous frameshift variant (p.Cys553Leufs∗16), and one homozygous stop-gain variant (p.Arg440Ter). To support the pathogenicity of the variants, we developed a novel CRISPR-Cas9-mediated tissue-specific knockout with cDNA rescue system for dOgdh, the Drosophila ortholog of human OGDHL. Pan-neuronal knockout of dOgdh led to developmental lethality as well as defects in Krebs cycle metabolism, which was fully rescued by expression of wild-type dOgdh. Studies using the Drosophila system indicate that p.Arg673Gln, p.Phe734Ser, and p.Arg299Gly are severe loss-of-function alleles, leading to developmental lethality, whereas p.Pro852Ala, p.Ala327Val, p.Trp220Cys, p.Asp491Val, and p.Arg244Trp are hypomorphic alleles, causing behavioral defects. Transcript analysis from fibroblasts obtained from the individual carrying the synonymous variant (c.1464T>C [p.Val488Val]) in family 2 showed that the synonymous variant affects splicing of exon 11 in OGDHL. Human neuronal cells with OGDHL knockout exhibited defects in mitochondrial respiration, indicating the essential role of OGDHL in mitochondrial metabolism in humans. Together, our data establish that the bi-allelic variants in OGDHL are pathogenic, leading to a Mendelian neurodevelopmental disease in humans.</description><subject>Alleles</subject><subject>Animals</subject><subject>Ataxia - genetics</subject><subject>bi-allelic</subject><subject>Cells, Cultured</subject><subject>Child</subject><subject>Cohort Studies</subject><subject>CRISPR-Cas9 gene editing</subject><subject>DEE</subject><subject>developmental and epileptic encephalopathy</subject><subject>DNA Mutational Analysis</subject><subject>Drosophila</subject><subject>Drosophila melanogaster - genetics</subject><subject>Epilepsy - genetics</subject><subject>exome sequencing</subject><subject>Family Health</subject><subject>Female</subject><subject>Fibroblasts</subject><subject>Hearing Loss - genetics</subject><subject>Humans</subject><subject>Ketoglutarate Dehydrogenase Complex - genetics</subject><subject>Male</subject><subject>mitochondria</subject><subject>Mutation</subject><subject>neurodevelopmental disease</subject><subject>Neurodevelopmental Disorders - genetics</subject><subject>OGDHL</subject><subject>RNA Splicing</subject><subject>Vision Disorders - genetics</subject><subject>α-ketoglutarate</subject><issn>0002-9297</issn><issn>1537-6605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2O1DAQhC0EYoeFF-CAfOQwCW47vxJCggV2kUbaC5ytjtOZ8cj5wU4i9g14bDzMsoILJ8v2V9WtKsZegkhBQPHmmOLxsE-lkJACpEKoR2wDuSqTohD5Y7YRQsiklnV5wZ6FcBQCoBLqKbtQWRXpQm3Yzw82QefIWcNX9BaHOXA78Nvrjzc7bnAJxJEPtPixpZXcOPU0zOh4mMjMful5awNhpDrCefF22HOarKMp3G35gfD3ixtD2PLVhiUqbT-h9SebLceh5TjjD4vP2ZMOXaAX9-cl-_b509erm2R3e_3l6v0uMVmezwkqQY2AvJWi6lAqkllTY4kN1VUhMllCA0BFR1lHRjWVqjNVZAZEK1W8gLpk786-09L01Jq4hkenJ2979Hd6RKv__RnsQe_HVVcl5FCpaPD63sCP3xcKs-5tMOQcDjQuQcsipl5loiwjKs-o8TEAT93DGBD6VKE-6lOF-lShBtCxlCh69feCD5I_nUXg7RmgGNNqyetgLA2GWutjJ7od7f_8fwHIBK_g</recordid><startdate>20211202</startdate><enddate>20211202</enddate><creator>Yap, Zheng Yie</creator><creator>Efthymiou, Stephanie</creator><creator>Seiffert, Simone</creator><creator>Vargas Parra, Karen</creator><creator>Lee, Sukyeong</creator><creator>Nasca, Alessia</creator><creator>Maroofian, Reza</creator><creator>Schrauwen, Isabelle</creator><creator>Pendziwiat, Manuela</creator><creator>Jung, Sunhee</creator><creator>Bhoj, Elizabeth</creator><creator>Striano, Pasquale</creator><creator>Mankad, Kshitij</creator><creator>Vona, Barbara</creator><creator>Cuddapah, Sanmati</creator><creator>Wagner, Anja</creator><creator>Alvi, Javeria Raza</creator><creator>Davoudi-Dehaghani, Elham</creator><creator>Fallah, Mohammad-Sadegh</creator><creator>Gannavarapu, Srinitya</creator><creator>Lamperti, Costanza</creator><creator>Legati, Andrea</creator><creator>Murtaza, Bibi Nazia</creator><creator>Nadeem, Muhammad Shahid</creator><creator>Rehman, Mujaddad Ur</creator><creator>Saeidi, Kolsoum</creator><creator>Salpietro, Vincenzo</creator><creator>von Spiczak, Sarah</creator><creator>Sandoval, Abigail</creator><creator>Zeinali, Sirous</creator><creator>Zeviani, Massimo</creator><creator>Reich, Adi</creator><creator>Jang, Cholsoon</creator><creator>Helbig, Ingo</creator><creator>Barakat, Tahsin Stefan</creator><creator>Ghezzi, Daniele</creator><creator>Leal, Suzanne M.</creator><creator>Weber, Yvonne</creator><creator>Houlden, Henry</creator><creator>Yoon, Wan Hee</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9459-3139</orcidid></search><sort><creationdate>20211202</creationdate><title>Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia</title><author>Yap, Zheng Yie ; Efthymiou, Stephanie ; Seiffert, Simone ; Vargas Parra, Karen ; Lee, Sukyeong ; Nasca, Alessia ; Maroofian, Reza ; Schrauwen, Isabelle ; Pendziwiat, Manuela ; Jung, Sunhee ; Bhoj, Elizabeth ; Striano, Pasquale ; Mankad, Kshitij ; Vona, Barbara ; Cuddapah, Sanmati ; Wagner, Anja ; Alvi, Javeria Raza ; Davoudi-Dehaghani, Elham ; Fallah, Mohammad-Sadegh ; Gannavarapu, Srinitya ; Lamperti, Costanza ; Legati, Andrea ; Murtaza, Bibi Nazia ; Nadeem, Muhammad Shahid ; Rehman, Mujaddad Ur ; Saeidi, Kolsoum ; Salpietro, Vincenzo ; von Spiczak, Sarah ; Sandoval, Abigail ; Zeinali, Sirous ; Zeviani, Massimo ; Reich, Adi ; Jang, Cholsoon ; Helbig, Ingo ; Barakat, Tahsin Stefan ; Ghezzi, Daniele ; Leal, Suzanne M. ; Weber, Yvonne ; Houlden, Henry ; Yoon, Wan Hee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-a30eb015d208fa23e24b9a7abe98604271b11e6fe4fec3b8394364c10d2383913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alleles</topic><topic>Animals</topic><topic>Ataxia - genetics</topic><topic>bi-allelic</topic><topic>Cells, Cultured</topic><topic>Child</topic><topic>Cohort Studies</topic><topic>CRISPR-Cas9 gene editing</topic><topic>DEE</topic><topic>developmental and epileptic encephalopathy</topic><topic>DNA Mutational Analysis</topic><topic>Drosophila</topic><topic>Drosophila melanogaster - genetics</topic><topic>Epilepsy - genetics</topic><topic>exome sequencing</topic><topic>Family Health</topic><topic>Female</topic><topic>Fibroblasts</topic><topic>Hearing Loss - genetics</topic><topic>Humans</topic><topic>Ketoglutarate Dehydrogenase Complex - genetics</topic><topic>Male</topic><topic>mitochondria</topic><topic>Mutation</topic><topic>neurodevelopmental disease</topic><topic>Neurodevelopmental Disorders - genetics</topic><topic>OGDHL</topic><topic>RNA Splicing</topic><topic>Vision Disorders - genetics</topic><topic>α-ketoglutarate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yap, Zheng Yie</creatorcontrib><creatorcontrib>Efthymiou, Stephanie</creatorcontrib><creatorcontrib>Seiffert, Simone</creatorcontrib><creatorcontrib>Vargas Parra, Karen</creatorcontrib><creatorcontrib>Lee, Sukyeong</creatorcontrib><creatorcontrib>Nasca, Alessia</creatorcontrib><creatorcontrib>Maroofian, Reza</creatorcontrib><creatorcontrib>Schrauwen, Isabelle</creatorcontrib><creatorcontrib>Pendziwiat, Manuela</creatorcontrib><creatorcontrib>Jung, Sunhee</creatorcontrib><creatorcontrib>Bhoj, Elizabeth</creatorcontrib><creatorcontrib>Striano, Pasquale</creatorcontrib><creatorcontrib>Mankad, Kshitij</creatorcontrib><creatorcontrib>Vona, Barbara</creatorcontrib><creatorcontrib>Cuddapah, Sanmati</creatorcontrib><creatorcontrib>Wagner, Anja</creatorcontrib><creatorcontrib>Alvi, Javeria Raza</creatorcontrib><creatorcontrib>Davoudi-Dehaghani, Elham</creatorcontrib><creatorcontrib>Fallah, Mohammad-Sadegh</creatorcontrib><creatorcontrib>Gannavarapu, Srinitya</creatorcontrib><creatorcontrib>Lamperti, Costanza</creatorcontrib><creatorcontrib>Legati, Andrea</creatorcontrib><creatorcontrib>Murtaza, Bibi Nazia</creatorcontrib><creatorcontrib>Nadeem, Muhammad Shahid</creatorcontrib><creatorcontrib>Rehman, Mujaddad Ur</creatorcontrib><creatorcontrib>Saeidi, Kolsoum</creatorcontrib><creatorcontrib>Salpietro, Vincenzo</creatorcontrib><creatorcontrib>von Spiczak, Sarah</creatorcontrib><creatorcontrib>Sandoval, Abigail</creatorcontrib><creatorcontrib>Zeinali, Sirous</creatorcontrib><creatorcontrib>Zeviani, Massimo</creatorcontrib><creatorcontrib>Reich, Adi</creatorcontrib><creatorcontrib>Jang, Cholsoon</creatorcontrib><creatorcontrib>Helbig, Ingo</creatorcontrib><creatorcontrib>Barakat, Tahsin Stefan</creatorcontrib><creatorcontrib>Ghezzi, Daniele</creatorcontrib><creatorcontrib>Leal, Suzanne M.</creatorcontrib><creatorcontrib>Weber, Yvonne</creatorcontrib><creatorcontrib>Houlden, Henry</creatorcontrib><creatorcontrib>Yoon, Wan Hee</creatorcontrib><creatorcontrib>SYNaPS Study Group</creatorcontrib><creatorcontrib>University of Washington Center for Mendelian Genomics</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of human genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yap, Zheng Yie</au><au>Efthymiou, Stephanie</au><au>Seiffert, Simone</au><au>Vargas Parra, Karen</au><au>Lee, Sukyeong</au><au>Nasca, Alessia</au><au>Maroofian, Reza</au><au>Schrauwen, Isabelle</au><au>Pendziwiat, Manuela</au><au>Jung, Sunhee</au><au>Bhoj, Elizabeth</au><au>Striano, Pasquale</au><au>Mankad, Kshitij</au><au>Vona, Barbara</au><au>Cuddapah, Sanmati</au><au>Wagner, Anja</au><au>Alvi, Javeria Raza</au><au>Davoudi-Dehaghani, Elham</au><au>Fallah, Mohammad-Sadegh</au><au>Gannavarapu, Srinitya</au><au>Lamperti, Costanza</au><au>Legati, Andrea</au><au>Murtaza, Bibi Nazia</au><au>Nadeem, Muhammad Shahid</au><au>Rehman, Mujaddad Ur</au><au>Saeidi, Kolsoum</au><au>Salpietro, Vincenzo</au><au>von Spiczak, Sarah</au><au>Sandoval, Abigail</au><au>Zeinali, Sirous</au><au>Zeviani, Massimo</au><au>Reich, Adi</au><au>Jang, Cholsoon</au><au>Helbig, Ingo</au><au>Barakat, Tahsin Stefan</au><au>Ghezzi, Daniele</au><au>Leal, Suzanne M.</au><au>Weber, Yvonne</au><au>Houlden, Henry</au><au>Yoon, Wan Hee</au><aucorp>SYNaPS Study Group</aucorp><aucorp>University of Washington Center for Mendelian Genomics</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia</atitle><jtitle>American journal of human genetics</jtitle><addtitle>Am J Hum Genet</addtitle><date>2021-12-02</date><risdate>2021</risdate><volume>108</volume><issue>12</issue><spage>2368</spage><epage>2384</epage><pages>2368-2384</pages><issn>0002-9297</issn><eissn>1537-6605</eissn><abstract>The 2-oxoglutarate dehydrogenase-like (OGDHL) protein is a rate-limiting enzyme in the Krebs cycle that plays a pivotal role in mitochondrial metabolism. OGDHL expression is restricted mainly to the brain in humans. Here, we report nine individuals from eight unrelated families carrying bi-allelic variants in OGDHL with a range of neurological and neurodevelopmental phenotypes including epilepsy, hearing loss, visual impairment, gait ataxia, microcephaly, and hypoplastic corpus callosum. The variants include three homozygous missense variants (p.Pro852Ala, p.Arg244Trp, and p.Arg299Gly), three compound heterozygous single-nucleotide variants (p.Arg673Gln/p.Val488Val, p.Phe734Ser/p.Ala327Val, and p.Trp220Cys/p.Asp491Val), one homozygous frameshift variant (p.Cys553Leufs∗16), and one homozygous stop-gain variant (p.Arg440Ter). To support the pathogenicity of the variants, we developed a novel CRISPR-Cas9-mediated tissue-specific knockout with cDNA rescue system for dOgdh, the Drosophila ortholog of human OGDHL. Pan-neuronal knockout of dOgdh led to developmental lethality as well as defects in Krebs cycle metabolism, which was fully rescued by expression of wild-type dOgdh. Studies using the Drosophila system indicate that p.Arg673Gln, p.Phe734Ser, and p.Arg299Gly are severe loss-of-function alleles, leading to developmental lethality, whereas p.Pro852Ala, p.Ala327Val, p.Trp220Cys, p.Asp491Val, and p.Arg244Trp are hypomorphic alleles, causing behavioral defects. Transcript analysis from fibroblasts obtained from the individual carrying the synonymous variant (c.1464T>C [p.Val488Val]) in family 2 showed that the synonymous variant affects splicing of exon 11 in OGDHL. Human neuronal cells with OGDHL knockout exhibited defects in mitochondrial respiration, indicating the essential role of OGDHL in mitochondrial metabolism in humans. Together, our data establish that the bi-allelic variants in OGDHL are pathogenic, leading to a Mendelian neurodevelopmental disease in humans.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34800363</pmid><doi>10.1016/j.ajhg.2021.11.003</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0002-9459-3139</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9297 |
ispartof | American journal of human genetics, 2021-12, Vol.108 (12), p.2368-2384 |
issn | 0002-9297 1537-6605 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8715183 |
source | MEDLINE; Cell Press Free Archives; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ScienceDirect Journals (5 years ago - present); PubMed Central |
subjects | Alleles Animals Ataxia - genetics bi-allelic Cells, Cultured Child Cohort Studies CRISPR-Cas9 gene editing DEE developmental and epileptic encephalopathy DNA Mutational Analysis Drosophila Drosophila melanogaster - genetics Epilepsy - genetics exome sequencing Family Health Female Fibroblasts Hearing Loss - genetics Humans Ketoglutarate Dehydrogenase Complex - genetics Male mitochondria Mutation neurodevelopmental disease Neurodevelopmental Disorders - genetics OGDHL RNA Splicing Vision Disorders - genetics α-ketoglutarate |
title | Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T00%3A34%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bi-allelic%20variants%20in%20OGDHL%20cause%20a%20neurodevelopmental%20spectrum%20disease%20featuring%20epilepsy,%20hearing%20loss,%20visual%20impairment,%20and%20ataxia&rft.jtitle=American%20journal%20of%20human%20genetics&rft.au=Yap,%20Zheng%20Yie&rft.aucorp=SYNaPS%20Study%20Group&rft.date=2021-12-02&rft.volume=108&rft.issue=12&rft.spage=2368&rft.epage=2384&rft.pages=2368-2384&rft.issn=0002-9297&rft.eissn=1537-6605&rft_id=info:doi/10.1016/j.ajhg.2021.11.003&rft_dat=%3Cproquest_pubme%3E2600284077%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2600284077&rft_id=info:pmid/34800363&rft_els_id=S0002929721004158&rfr_iscdi=true |